BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6518242)

  • 1. Efficiencies of experimental designs for an illness-death model.
    Borgan O; Liestøl K; Ebbesen P
    Biometrics; 1984 Sep; 40(3):627-38. PubMed ID: 6518242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An illness-death model for the study of the carcinogenic process using survival/sacrifice data.
    Kodell RL; Nelson CJ
    Biometrics; 1980 Jun; 36(2):267-77. PubMed ID: 7407315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A continuous time version and a generalization of a Markov-recapture model for trapping experiments.
    Alpizar-Jara R; Smith CE
    Math Biosci; 2008; 214(1-2):11-9. PubMed ID: 18556026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Log-linear models in the analysis of disease prevalence data from survival/sacrifice experiments.
    Mitchell TJ; Turnbull BW
    Biometrics; 1979 Mar; 35(1):221-34. PubMed ID: 315241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory analysis of disease prevalence data from survival/sacrifice experiments.
    Turnbull BW; Mitchell TJ
    Biometrics; 1978 Dec; 34(4):555-70. PubMed ID: 749944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biological marker model for predicting disease transitions.
    Klein JP; Klotz JH; Grever MR
    Biometrics; 1984 Dec; 40(4):927-36. PubMed ID: 6598390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonparametric methods for survival/sacrifice experiments.
    Dewanji A; Kalbfleisch JD
    Biometrics; 1986 Jun; 42(2):325-41. PubMed ID: 3741974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing a model of aging in animal experiments.
    Tyurin YuN ; Yakovlev AYu ; Shi J; Bass L
    Biometrics; 1995 Mar; 51(1):363-72. PubMed ID: 7766791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric estimation of the distribution of time to onset for specific diseases in survival/sacrifice experiments.
    Turnbull BW; Mitchell TJ
    Biometrics; 1984 Mar; 40(1):41-50. PubMed ID: 6733233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based analysis of survival experiments with zero and non-zero final survivors.
    Sühnel J
    Z Versuchstierkd; 1989; 32(4):157-65. PubMed ID: 2626881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the efficiency of age-adjusted tests in animal carcinogenicity experiments.
    Gart JJ; Tarone RE
    Biometrics; 1987 Mar; 43(1):235-44. PubMed ID: 3567308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Markov model for sequences of ordinal data from a relapsing-remitting disease.
    Albert PS
    Biometrics; 1994 Mar; 50(1):51-60. PubMed ID: 8086615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.
    Boher JM; Pujol JL; Grenier J; Daurès JP
    Br J Cancer; 1999 Mar; 79(9-10):1419-27. PubMed ID: 10188885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A random effects model for multistate survival analysis with application to bone marrow transplants.
    Bhattacharyya M; Klein JP
    Math Biosci; 2005 Mar; 194(1):37-48. PubMed ID: 15836863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial multistate transitional models for longitudinal event data.
    Nathoo FS; Dean CB
    Biometrics; 2008 Mar; 64(1):271-9. PubMed ID: 17425639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analysis of asthma control under a Markov assumption with use of covariates.
    Saint-Pierre P; Combescure C; Daurès JP; Godard P
    Stat Med; 2003 Dec; 22(24):3755-70. PubMed ID: 14673936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. tdc.msm: an R library for the analysis of multi-state survival data.
    Meira-Machado L; Cadarso-Suárez C; de Uña-Alvarez J
    Comput Methods Programs Biomed; 2007 May; 86(2):131-40. PubMed ID: 17350136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hidden Markov model-based approach for identifying timing differences in gene expression under different experimental factors.
    Yoneya T; Mamitsuka H
    Bioinformatics; 2007 Apr; 23(7):842-9. PubMed ID: 17237042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A joint frailty model for survival and gap times between recurrent events.
    Huang X; Liu L
    Biometrics; 2007 Jun; 63(2):389-97. PubMed ID: 17688491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality modeling of early detection programs.
    Lee SJ; Zelen M
    Biometrics; 2008 Jun; 64(2):386-95. PubMed ID: 17725809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.